The Information Services team have received a few calls from pharmacists requesting more information about the various brands of enoxaparin pre-filled injections.
We want to remind our members of the MHRA guidance that recommends that biosimilar products should be prescribed by brand and that patients should ideally remain on the same brand.
Pharmacists presented with a generic prescription for enoxaparin should take steps to confirm the brand required before dispensing a product. A record of the brand supplied should be made on the patient’s PMR to ensure continuity of supply.
For more information visit our Medicines and Safety advice page: